Preview

Epidemiology and Vaccinal Prevention

Advanced search

Epidemiological Characteristics of Acute Rheumatic Fever and Chronic Rheumatic Heart Disease in the Russian Federation and Moscow, 2012–2024

https://doi.org/10.31631/2073-3046-2026-25-3-12-27

Abstract

Relevance. Acute rheumatic fever (ARF) and chronic rheumatic heart disease (CRHD) remain important medical and social problems despite a declining prevalence in most developed countries. These conditions are late complications of group A streptococcal infection and are associated with chronic valvular heart disease, disability, and premature mortality. Current evidence indicates persistent regional disparities in disease distribution and possible underestimation of the true disease burden.

Aim. To assess long-term trends in the incidence, prevalence, and mortality of ARF and CRHD in the Russian Federation and Moscow during 2012–2024 and to evaluate age-specific and territorial characteristics of disease distribution.

Materials and Methods. A retrospective descriptive epidemiological study was conducted. Data were obtained from Federal Statistical Reporting Forms No. 12 and No. 14. Analyses were performed for the total population and for the following age groups: children aged 0–14 years, adolescents aged 15–17 years, adults aged ≥ 18 years, working-age population, and older-than-working-age population. Incidence, prevalence, and mortality rates per 100,000 population, average long-term rates (ALR), average annual growth rates (AAGR), and trend significance coefficients (t) were calculated. Time-series analysis was performed using the least-squares method with trend-line construction.

Results. A total of 24,815 cases of acute rheumatic fever (ARF) and 110,255 newly diagnosed cases of chronic rheumatic heart disease (CRHD) were registered in the Russian Federation between 2012 and 2024. A statistically significant decline in the main epidemiological indicators was observed. The incidence of ARF decreased 4.3-fold, from 1.76 to 0.41 per 100,000 population (AAGR = -9.6 %; p < 0.001). The incidence of CRHD decreased 1.8-fold, from 7.31 to 4.09 per 100,000 population (AAGR = -6.2 %; p < 0.001), while the prevalence of CRHD decreased 2.0-fold, from 130.88 to 66.06 per 100,000 population (AAGR = -5.8 %; p < 0.001). Mortality from ARF decreased 9.7-fold, from 0.03 to 0.003 per 100,000 population, whereas mortality from CRHD decreased 1.8-fold, from 1.09 to 0.60 per 100,000 population. The highest ARF incidence (ALR = 5.06 per 100,000 population), CRHD incidence (ALR = 13.67 per 100,000 population), and CRHD prevalence (ALR = 194.68 per 100,000 population) were observed in the North Caucasian Federal District. The highest ARF incidence was recorded among adolescents aged 15–17 years (ALR = 3.62 per 100,000 population), whereas CRHD predominantly affected individuals older than working age, with average long-term incidence and prevalence rates of 8.27 and 210.53 per 100,000 population, respectively. In Moscow, the main epidemiological indicators of ARF and CRHD were lower than the national averages and also demonstrated statistically significant declines over the study period.

Conclusion. A decrease in the incidence, prevalence, and mortality associated with ARF and CRHD was observed in the Russian Federation and Moscow during 2012–2024. However, pronounced territorial disparities and age-related differences in disease distribution persist. These findings highlight the need for further improvement of epidemiological surveillance, prevention of group A streptococcal infection and its complications, and early detection of post-streptococcal diseases.

About the Authors

N. V. Nikitin
Sechenov University
Russian Federation

Nikita V. Nikitin – Assistant of the Department of Epidemiology and Evidence-Based Medicine

2/2 Bolshaya Pirogovskaya str., Moscow, 119991

+7 (915) 964-42-45



E. V. Glushkova
Sechenov University
Russian Federation

Ekaterina V. Glushkova – Cand. Sci. (Med.), Associate Professor of the Department of Epidemiology and Evidence-Based Medicine

Moscow

+7 (985) 649-13-24



A. Y. Brazhnikov
Sechenov University
Russian Federation

Alexey Y. Brazhnikov – Cand. Sci. (Med.), Associate Professor of the Department of Epidemiology and Evidence-Based Medicine

Moscow

+7 (910) 494-78-01



A. O. Sukhareva
Sechenov University
Russian Federation

Anastasia O. Sukhareva – student

Moscow

+7 (903) 878-39-85



E. A. Sakharova
Sechenov University
Russian Federation

Ekaterina A. Sakharova – student

Moscow

+7 (905) 057-37-54



N. I. Briko
Sechenov University
Russian Federation

Nikolay I. Briko – Academician of the Russian Academy of Sciences, Dr. Sci. (Med.), Professor, Head of the Department of Epidemiology and Evidence-
Based Medicine

Moscow

+7 (499) 248-31-00



References

1. Barth DD, Mullane MJ, Sampson C, et al. Missing Piece Study protocol: prospective surveillance to determine the epidemiology of group A streptococcal pharyngitis and impetigo in remote Western Australia. BMJ Open. 2022;12:e057296. doi:10.1136/bmjopen-2021-057296.

2. Passos LSA, Nunes MCP, Aikawa E. Rheumatic heart valve disease pathophysiology and underlying mechanisms. Front Cardiovasc Med. 2020;7:612716. doi:10.3389/fcvm.2020.612716.

3. Lawrence JG, Carapetis JR, Griffiths K, et al. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997–2010. Circulation. 2013;128(5):492–501. doi:10.1161/CIRCULATIONAHA.113.001477.

4. He VY, Condon JR, Ralph AP, et al. Long-term outcomes from acute rheumatic fever and rheumatic heart disease: a data-linkage and survival analysis approach. Circulation. 2016;134(3):222–232. doi:10.1161/CIRCULATIONAHA.115.020966.

5. Oliver J, Robertson O, Zhang J, et al. Ethnically disparate disease progression and outcomes among acute rheumatic fever patients in New Zealand, 1989–2015. Emerg Infect Dis. 2021;27(7):1893–1902. doi:10.3201/eid2707.204558.

6. World Health Organization. Rheumatic heart disease (fact sheet). Available from: https://www.who.int/news-room/fact-sheets/detail/rheumatic-heart-disease (accessed 23.12.2025).

7. Zou Y, Wei S, Ren Q, et al. Global Burden of Rheumatic Heart Disease (1990-2021), Attributable Risk Factors, and Future Projections. JACC Basic Transl Sci. 2026;11(4):101511. doi:10.1016/j.jacbts.2026.101511.

8. Aksenova AV, Abeldyaev DV, Glushkova EV. Epidemiological aspects of streptococcal and post-streptococcal diseases in the Russian Federation at the present stage. Klinitsist. 2020;14(1–2):14–23. (In Russ.). doi:10.17650/1818-8338-2020-14-1-2-14-23.

9. Descriptive epidemiological study (retrospective epidemiological analysis), a textbook for students of medical universities / V.I. Pokrovsky, N.N. Filatov, I.P. Paltyshev. - Moscow: Sanepidmedia, 2005. – 239 p. ill.; 20. – ISBN 5-902586-14-3.

10. Watkins DA, Beaton AZ, Carapetis JR, et al. Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel. J Am Coll Cardiol. 2018;72(12):1397–1416. doi:10.1016/j.jacc.2018.06.063.

11. Zühlke L, Beaton A, Engel ME, et al. Group A streptococcus, acute rheumatic fever and rheumatic heart disease: epidemiology and clinical considerations. Nat Rev Dis Primers. 2017;3:15084. doi:10.1038/nrdp.2015.84.

12. Briko NI, Glushkova EV. State and trends of the epidemic situation of streptococcal (group A) infection in Russia in recent years. Journal of Microbiology, Epidemiology and Immunobiology. 2018;(1):10–16. (In Russ.).

13. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012;379(9819):953–964. doi:10.1016/S0140-6736(11)61171-9.

14. Chen Y, Zhao H, Wang Q, et al. Global burden and trend of rheumatic heart disease among women of childbearing age from 1990 to 2021. BMC Cardiovasc Disord. 2025;25:112. doi:10.1186/s12872-025-04112-6.

15. Andriyashkina DY, Shostak NA, Aksenova AV, et al. Acute rheumatic fever and rheumatic heart disease: what’s new? Klinitsist. 2023;17(1):12–20. (In Russ.). doi:10.17650/1818-8338-2023-17-1-K678.

16. Zhang J, Li X, Wang H, et al. Global trends and burden of rheumatic heart disease from 1990 to 2021: an updated analysis of the Global Burden of Disease Study. Front Public Health. 2025;13:1674434. doi:10.3389/fpubh.2025.1674434


Review

For citations:


Nikitin N.V., Glushkova E.V., Brazhnikov A.Y., Sukhareva A.O., Sakharova E.A., Briko N.I. Epidemiological Characteristics of Acute Rheumatic Fever and Chronic Rheumatic Heart Disease in the Russian Federation and Moscow, 2012–2024. Epidemiology and Vaccinal Prevention. 2026;25(3):12-27. (In Russ.) https://doi.org/10.31631/2073-3046-2026-25-3-12-27

Views: 15

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-3046 (Print)
ISSN 2619-0494 (Online)